Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-17

Clinical Trial Update: Neuromodulation for Schizophrenia [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate a neuromodulation therapy for schizophrenia, sponsored by Scion NeuroStim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Scion NeuroStim | Conditions: Schizophrenia | NA | Status: RECRUITING